Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Works in Dermatology · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Oncology · Renal & urogenital · Respiratory
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) is a clinical trial sponsor. It has no active clinical trials as lead sponsor; its trials since 2021 were across 8 therapeutic areas. Since 2021 it has completed 3 trials and stopped 3 early.
Trial track record · since 2021
Pipeline · 0 active trials
No active trials with this company as lead sponsor.
Questions about Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) has no active clinical trials as lead sponsor on ClinicalTrials.gov. Since 2021 it has completed 3 trials and stopped 3 early.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA); every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2024-01-23.
Approve Suite is not affiliated with Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA).
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.